The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB90 Holdings Regulatory News (B90)

Share Price Information for B90 Holdings (B90)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.70
Bid: 2.60
Ask: 2.80
Change: -0.05 (-1.82%)
Spread: 0.20 (7.692%)
Open: 2.75
High: 2.75
Low: 2.65
Prev. Close: 2.75
B90 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Subscription and Board Appointment

16 May 2022 07:00

RNS Number : 5306L
B90 Holdings PLC
16 May 2022
 

Strictly embargoed until: 07.00, 16th May 2022

 

B90 Holdings plc

("B90", the "Company" or "Group")

 

Subscription to raise £731,000 and Board Appointment

 

Subscription

 

B90 Holdings plc (AIM: B90), the online marketing and operating company for the gaming industry, is pleased to announce that it has raised £731,000 (before expenses) through a subscription for 12,713,043 new ordinary shares of no par value in the capital of the Company ("Ordinary Shares") (the "Subscription Shares") by certain existing investors at a price of 5.75 pence per share (the "Issue Price") (the "Subscription").

 

The Issue Price equals the Company's closing middle market share price on 13 May 2022, being the last practicable business day prior to this announcement. The Subscription Shares represent 5.0% of the Company's existing issued share capital (inclusive of the deferred consideration shares, announced on 13 May 2022). The Subscription is conditional on, inter alia, Admission (as defined below).

 

The proceeds of the Subscription will be utilised for marketing activities and working capital.

 

 

Board Appointment

 

The Company also announces that current Non-Executive Chairman, Karim Peer, has been appointed as the Company's new Executive Chairman with immediate effect. Karim has over 25 years' experience in building and successfully exiting companies. Formerly Managing Director of Open Bet, a leading provider of sportsbook, casino gaming and betting shop technology, Karim led the business when it acquired Alphameric plc and oversaw substantial profit growth. He was then part of the team that sold Open Bet to Vitruvian Partners for more than £200m. Karim was also CEO of Financial Objects plc which, under his leadership, was sold in 2008 to a Swiss listed software group, achieving a 90% premium to the then prevailing share price.

 

The Company recognises the need to enhance its board composition, and intends to appoint at least one independent Non-executive director as soon as reasonably practicable. Further announcements will be made as appropriate.

 

Karim Peer, Executive Chairman, commented:

 

"The proceeds from this Subscription place the Group on a more stable financial footing and enable the activation of additional marketing initiatives to drive revenue. By enhancing our well established direct to customer routes we will continue to introduce and augment our brands in new and different markets, facilitating more growth and accelerating customer acquisition. We are already making significant operational and financial progress and customer numbers are increasing across our territories, particularly in South America, with good customer acquisition numbers; and retention rates and average spend increasing when compared to last year. With a number of high profile events scheduled for this year, not least the FIFA World Cup Qatar 2022, we are increasingly optimistic about the prospects for the Group."

 

 

Admission

 

When issued, the Subscription Shares will rank pari passu with the existing Ordinary Shares and application is being made to the London Stock Exchange plc for admission of the new Ordinary Shares to trading on AIM ("Admission"). The Subscription is conditional on, inter alia, Admission and dealings are expected to commence at 08.00am on 20 May 2022.

 

Total voting rights

 

Following Admission, the Company's total issued share capital will consist of 264,572,258 Ordinary Shares with voting rights. The Company does not hold any Ordinary Shares in treasury and accordingly there are no voting rights in respect of any treasury shares. On Admission, the abovementioned figure of 264,572,258 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, B90 under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

-ends-

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended).

 

For further information please contact:

 

B90 Holdings plc +44 (0)1624 605 764

Karim Peer, Non-Executive Chairman

Marcel Noordeloos, Chief Financial Officer

 

Strand Hanson Limited (Nominated Adviser) +44 (0)20 7409 3494

James Harris / Richard Johnson / Rob Patrick

 

Whitman Howard Ltd (Broker)

Nick Lovering

 

Belvedere (Financial PR & IR) +44 (0)20 3687 2754

John West / Llewellyn Angus

 

About B90 Holdings plc

B90 Holdings plc is a group of companies focused on the operation of its own online Sportsbook and Casino product as well as marketing activities for other online gaming companies.

 

Website: www.b90holdings.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURAAMRTMTIBBMT
Date   Source Headline
18th Apr 20247:00 amRNSOddsen.nu goes global
25th Mar 20247:00 amRNSTR-1
25th Mar 20247:00 amRNSTR-1
5th Mar 20247:00 amRNSDirector Dealings
1st Mar 20247:00 amRNSTR-1
1st Feb 20247:00 amRNSTrading Update
22nd Jan 20242:30 pmRNSDirector Dealings
8th Nov 20237:00 amRNSShift to B2B Operations: Relaunch of Bet90.com
30th Oct 20237:00 amRNSGrant of Options
28th Sep 20237:00 amRNSUnaudited Interim Results
15th Sep 20237:00 amRNSPlacing and Subscription, Conversion of CLNs
14th Aug 20237:00 amRNSAppointments: NED; Chief Finance, M&A Dev. Officer
31st Jul 20233:14 pmRNSResult of AGM
17th Jul 202311:28 amRNSPosting of AGM Notice
13th Jul 20237:00 amRNSFURTHER RE SUBSCRIPTION
12th Jul 20237:00 amRNSAcquisition of Emwys; Licence Agreement; CLN issue
30th Jun 20237:01 amRNSFundraising and Board Changes
30th Jun 20237:00 amRNSFinal Results
6th Jun 20237:00 amRNSAppointment of New Broker
28th Apr 20235:02 pmRNSDirector’s purchase of shares
21st Apr 20231:21 pmRNSDirector’s purchase of shares
19th Apr 20237:00 amRNSGrant of Options
5th Apr 20232:10 pmRNSRaise of a further £1.1 million
20th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20232:05 pmRNSSecond Price Monitoring Extn
21st Feb 20232:00 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSMark Blandford Appointed as Strategic Adviser
6th Feb 20237:00 amRNS£0.5 million Raise and Trading Update
3rd Feb 20237:00 amRNSChange of Adviser
23rd Dec 20227:00 amRNSB90 raises £0.5 million via Convertible Loan Notes
7th Nov 202211:43 amRNSAdjournment of Requisitioned EGM
7th Nov 20227:35 amRNSWithdrawal of Requisition and Directorate Changes
18th Oct 20227:00 amRNSDirector Dealing
17th Oct 202212:18 pmRNSPublication of Circular and Notice of EGM
27th Sep 20222:52 pmRNSUpdate to Requisition to Convene Extraordinary GM
26th Sep 20227:00 amRNSAppointment of Independent Non-Executive Director
23rd Sep 20227:00 amRNSUNAUDITED INTERIM RESULTS
23rd Sep 20227:00 amRNSUNAUDITED INTERIM RESULTS
20th Sep 20223:33 pmRNSExtraordinary General Meeting
14th Sep 20222:22 pmRNSResult of AGM
9th Sep 20227:00 amRNSSubscription to raise £305,000
31st Aug 20227:00 amRNSPosting of AGM Notice
1st Jul 20227:00 amRNSAppointment of New Broker
22nd Jun 20227:00 amRNSGrant of Options
21st Jun 20227:02 amRNSAcquisition of T4U Marketing Ltd
21st Jun 20227:00 amRNSFinal Results
16th May 20227:00 amRNSSubscription and Board Appointment
13th May 20224:03 pmRNSOddsen Acquisition Update
22nd Dec 20217:00 amRNSAcquisition
9th Dec 20217:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.